The latest report by IMARC Group, titled “Artificial Insemination Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. The global artificial insemination market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 9.13% during 2023-2028.
Artificial insemination is a medical procedure used in reproductive medicine and animal breeding. It involves the deliberate introduction of sperm into the female reproductive tract, typically the uterus or cervix, without natural sexual intercourse. It is employed to facilitate fertilization when natural conception is challenging or in cases where controlled breeding is desired. In human medicine, artificial insemination is often recommended for couples facing fertility issues, such as male infertility or unexplained fertility problems. It facilitates the direct delivery of sperm to the woman’s reproductive organs, improving the chances of successful conception. There are two primary methods of artificial insemination in humans: intrauterine insemination (IUI) and intracervical insemination (ICI). In animal breeding, artificial insemination is a common practice to enhance genetic traits and control breeding outcomes in livestock and other animals. At present, artificial insemination finds extensive applications in human fertility treatments and livestock breeding across the globe, revolutionizing reproductive practices in both contexts.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/artificial-insemination-market/requestsample
Artificial Insemination Market Trends and Drivers:
The global artificial insemination market is primarily driven by the rising adoption of artificial insemination to enhance breeding efficiency and productivity in both human and animal sectors due to the expanding population and increasing demand for livestock products. Apart from this, ongoing advancements in assisted reproductive technologies, including improved semen quality and insemination techniques, are fostering market growth. Moreover, the growing awareness of genetic improvement in livestock and the escalating need for controlled breeding to maintain desirable traits have augmented the demand for artificial insemination in agriculture. Additionally, in the healthcare sector, factors such as increasing infertility rates, delayed pregnancies, and same-sex couples seeking reproductive assistance are propelling market growth. Besides this, the exchange of superior genetic material owing to the rapid globalization of the dairy and livestock industries has catalyzed market growth. Furthermore, several favorable government initiatives, subsidies, and supportive regulatory frameworks have accelerated the adoption of artificial insemination techniques, thereby contributing to market growth.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Type:
- Intrauterine
- Intracervical
- Intravaginal
- Intratubal
Breakup by Source Type:
- AIH-Husband
- AID-Donor
Breakup by End Use:
- Hospitals and Clinics
- Fertility Centers
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Conceivex Inc.
- FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation)
- Genea Limited
- Genus plc
- Hamilton Thorne Inc.
- Hi-Tech Solutions
- Kitazato Corporation
- Pride Angel
- Rinovum Women’s Health LLC
- Rocket Medical plc
- TenderNeeds Fertility LLC
- Vitrolife AB.
Explore full report with table of contents: https://www.imarcgroup.com/artificial-insemination-market
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
